Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

Adv Pharm Bull. 2019;9(3): 497-504. doi: 10.15171/apb.2019.059

PMID: 31592436 PMCID: PMC6773934

Research Article

Evaluating the Differential Effects of Valproic Acid on Wharton’s Jelly Mesenchymal Stem Cells

Homa Salami ¹, Seyed Javad Mowal ¹ , Rasoul Moukhah ², Zahra Hajebrahimi ³ , Seyed Abdolhakim Hosseini ⁴ , Houri Edalat ⁵ *

Cited by CrossRef: 5

1- Sodomaco A, Bernardi I, Rambaldi A, Lombardi P, Rossi M, Paris F, Manzoli L, Ratti S, Alviano F. Mesenchymal Stromal Cell Rejuvenation Strategies to Enhance Clinical Translation in Cell Therapy. Aging Cell. 2026;25(8) [Crossref]

2- Shokeir A, Awadalla A, Hamam E, Hussein A, Mahdi M, Abosteta A, Shahin M, Barakat N, El-Adl M, El-Sherbiny M, Eldesoqui M, AlMadani M, Ali S, El-Sherbini E, Khirallah S. Human Wharton's jelly-derived mesenchymal stromal stem cells preconditioned with valproic acid promote cell migration and reduce renal inflammation in ischemia/reperfusion injury by activating the AKT/P13K and SDF1/CXCR4 pathways. Archives of Biochemistry and Biophysics. 2024;755:109985 [Crossref]

3- Azarbarz N, Nejaddehbashi F, Khorsandi L, Bijan Nejad D, Sayyahi A. Autophagy enhances the differentiation of insulin-producing cells from Wharton’s jelly-derived mesenchymal stem cells. Tissue and Cell. 2024;88:102384 [Crossref]

4- Ghorbaninejad M, Khademi-Shirvan M, Hosseini S, Baghaban Eslaminejad M. Epidrugs: novel epigenetic regulators that open a new window for targeting osteoblast differentiation. Stem Cell Res Ther. 2020;11(1) [Crossref]

5- Hejazi S, Maleki M, Rasekh M. Study of the Cellular Senescence Process in Human Umbilical Cord Wharton's Jelly-derived Mesenchymal Stem Cells. 2023;13(4):361 [Crossref]

6- Işıldar B, Özkan S, Koyutürk M. Preconditioning of Human Umbilical Cord Mesenchymal Stem Cells with a Histone Deacetylase Inhibitor: Valproic Acid. Balkan Med J. 2024;:369 [Crossref]